期刊文献+

小肠间质瘤预后因素分析 被引量:16

Analysis of prognostic factors in gastrointestinal stromal tumors of the small intestine
原文传递
导出
摘要 目的探讨小肠间质瘤预后相关因素。方法复阅病理切片(苏木精-伊红染色),重新诊断;两点取材构建组织微阵列,免疫组织化学染色检测CD117、CD34、SMA、Desmin、S-100、Ki-67、P53及bcl-2蛋白等8种抗体表达;单因素分析各变量与患者预后的关系。结果58例患者1、3、5年生存率分别为98.3%、69.7%、50.9%。单因素分析,患者预后仅与肿瘤大小及性别有关(P<0.05)。结论对男性小肠间质瘤患者应加以关注,小肠间质瘤直径大于5cm,应高度警惕其复发转移。 Objective To explore the prognostic factors in patients with gas tr ointestinal stromal tumors of the small intestine. Methods Tumor slides stained with hematoxylin and eosin from these patients were reviewed. Two histomorpholog ically representative areas were indentified and arrayed on a tissue microarray. Immunohistochemistry staining were performed using antibodies to detect the exp ression of c kit protein(CD117),CD34,smooth muscle actin,desmin,S 100,Ki 67,P 53 and bcl 2 protein. The relationship between clinicopathologic features and p rognosis was analyzed by univariate analysis. Results The 1 ,3 ,5 year surviv al rate of 58 such patients were 98.3%,69.7%,and 50.9%respectively. The progn osis was related with tumor size and gender by univariate analysis(P< 0.05). Con clusion More attention should be paid to the male patients with small intestine stromal tumors,especially those with tumors size>5 cm,because those tumors are m ore likely to metastasize than smaller tumors(≤5 cm).
出处 《中华胃肠外科杂志》 CAS 2005年第3期213-216,共4页 Chinese Journal of Gastrointestinal Surgery
  • 相关文献

参考文献9

  • 1Singer S,Rubin BP,Lux ML,et al. Prognostic value of KIT mutation type,mitotic activity,and histologic subtype in gastrointestinal stromal tumors. J Clin Oncol,2002,20:3898- 3905.
  • 2Crosby JA,Catton CN,Davis A,et al. Malignant gastrointestinal stromal tumors of the small intestine:a review of 50 cases from a prospective database. Ann Surg Oncol,2001,8:50- 59.
  • 3DeMatteo RP,Lewis JJ,Leung D,et al. Two hundred gastrointestinal stromal tumors:recurrence patterns and prognostic factors for survival. Ann Surg,2000,231:51- 58.
  • 4Clary BM,DeMatteo RP,Lewis JJ,et al. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum:a clinical comparison. Ann Surg Oncol,2001,8:290- 299.
  • 5Emory TS,Sobin LH,Lukes L,et al. Prognosis of gastrointestinal smooth- muscle (stromal) tumors:dependence on anatomic site. Am J Surg Pathol,1999,23:82- 87.
  • 6Yan H,Marchettini P,Acherman YI,et al. Prognostic assessment of gastrointestinal stromal tumor. Am J Clin Oncol,2003,26:221- 228.
  • 7Verweij J,van Oosterom A,Blay JY,et al. Imatinib mesylate (STI- 571 Glivec,Gleevec) is an active agent for gastrointestinal stromal tumours,but does not yield responses in other soft- tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group Phase Ⅱ Study. Eur J Cancer,2003,39:2006- 2011.
  • 8Rudolph P,Gloeckner K,Parwaresch R,et al. Immunophenotype,proliferation,DNA ploidy,and biological behavior of gastroi- ntestinal stromal tumors:a multivariate clinicopathologic study. Hum Pathol,1998,29:791- 800.
  • 9Cunningham RE,Abbondanzo SL,Chu WS,et al. Apoptosis,bcl- 2 expression,and p53 expression in gastrointestinal stromal/smooth muscle tumors. Appl Immunohistochem Mol Morphol,2001, 9:19- 23.

同被引文献99

引证文献16

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部